Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer
Clinical trial NCT03519230 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03519230
- Sponsor
- BeiGene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-14
- Primary completion
- 2025-12-01
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.